Côlon & Rectum

, Volume 2, Issue 1, pp 5–9 | Cite as

Colite aiguë grave au cours des MICI: l’étape diagnostique

Dossier Thématique / Thematic File

Résumé

Évaluer la sévérité d’une colite est un objectif important pour le clinicien parce que, de cette évaluation, dépendent les stratégies thérapeutiques médicamenteuses et l’opportunité d’un geste de colectomie en urgence pour améliorer à la fois le pronostic et la mortalité des malades souffrant de cette affection. Aucun score clinique ou d’imagerie de référence ne peut être préféré, mais la combinaison des différents critères pronostiques est utile.

Mots clés

Colite aiguë grave Rectocolite hémorragique Maladie de Crohn Colectasie 

Severe colitis: diagnosis step

Abstract

Assessment of severity of colitis remains an important goal for physicians because both adequate drug strategies and the opportunity to perform emergency colectomies to improve mortality rates and prognosis depend on this assessment. Neither clinical nor imaging score is a gold standard but combined assessment is helpful.

Keywords

Severe acute colitis Ulcerative colitis Crohn’s disease Toxic megacolon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Bouhnik Y, Vahedi K, Bitou NA, Matuchansky C (1998) Colites aiguës graves au cours des maladies inflammatoires chroniques de l’intestin. In: Rambaud JC (ed.) Les maladies inflammatoires chroniques de l’intestin. John Libbey Eurotext 155–174Google Scholar
  2. 2.
    Lavergne-Slove A (1998) Anatomopathologie. In: Rambaud JC (ed.) Les maladies inflammatoires chroniques de l’intestin. John Libbey Eurotext 11–25Google Scholar
  3. 3.
    Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1041–1048Google Scholar
  4. 4.
    Truelove SC, Jewell DP (1974) Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1: 1067–1070PubMedCrossRefGoogle Scholar
  5. 5.
    Travis SPL, Farrant JM, Ricketts C, et al. (1996) Predicting outcome in severe ulcerative colitis. Gut 38: 905–910PubMedCrossRefGoogle Scholar
  6. 6.
    Seo M, Okada M, Yao T, et al. (1992) An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 87: 971–976PubMedGoogle Scholar
  7. 7.
    Seo M, Okada M, Yao T, et al. (2002) Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index. J Gastroenterol 37: 91–94CrossRefGoogle Scholar
  8. 8.
    Lichtiger S, Present DH, Kornbluth A, et al. (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841–1845PubMedCrossRefGoogle Scholar
  9. 9.
    Schroeder KW, Tremaine WJ, Illstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317: 1625–1629PubMedCrossRefGoogle Scholar
  10. 10.
    Best WR, Becktel JM, Singleton JW (1979) Rederived values of the eight coefficients of the Crohn’s disease activity index (CDAI). Gastroenterology 77: 843–846PubMedGoogle Scholar
  11. 11.
    Carbonnel F, Lavergne A, Lemann A, et al. (1994) Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 39: 1550–1557PubMedCrossRefGoogle Scholar

Copyright information

© Springer Verlag France 2008

Authors and Affiliations

  1. 1.Service d’hépatogastroentérologieCHU de Nancy-BraboisVandœuvre-lès-NancyFrance

Personalised recommendations